©2021-2032 All Rights Reserved. Online Journal
of Veterinary Research. You may not store these pages in any form except for
your own personal use. All other usage or distribution is illegal under
International copyright treaties. Permission to use any of these pages in any
other way besides the before mentioned must be gained in writing from the
publisher. This article is exclusively copyrighted in its entirety to OJVR
publications. This article may be copied once but may not be, reproduced or
re-transmitted without the express permission of the editor.
OJVRTM
Online Journal of Veterinary
Research©
(Including
Medical and Laboratory Research)
Established 1994
ISSN 1328-925X
Volume
25 (9):631-652, 2021.
Pharmacology
of Astragalus
polysaccharides for Veterinary therapeutics.
Li Hongquan
College
of Veterinary Medicine and Animal Science, Shanxi Agricultural University, Taigu, Shanxi 030801, PRC, China.
ABSTRACT
Hongquan L.,
Pharmacology of Astragalus polysaccharides in
Veterinary therapeutics, Onl J Vet Res., 25 (9):631-652, 2021. Radix Astragali has been used as a
tonic, hepato-protective, diuretic,
antiperspirant, expectorant and sedative. Astralagus
derives from dried roots of Astragalus membranaceus, A.
mongholious, and A. membranaceus.
Ingredients associated with bioactivity in R
Astragali include polysaccharides, saponins, lavonoids, alkaloids, amino
acids, linoleic acid, and trace elements. Studies suggest that these
constituents possess anti-aging, antioxidant, hypertensive, cancer, diabetic, stress,
immunomodulatory, microbial and protozoal properties but recently
newer active components have been found. Although R. Astragali has a long history of
medicinal use chemo-pharmacological properties and clinical applications have
not been described and mechanisms of action are not completely understood. Author
reports recent advances in the pharmacology of Astragalus polysaccharide (APS)
for Veterinary use.
Key words: Pharmacology; Immunology; Astragalus Polysaccharides (APS); Animals